Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2008

01.04.2008 | Original Paper

Effect of a Gluten-free Diet on the Risk of Enteropathy-associated T-cell Lymphoma in Celiac Disease

verfasst von: Marco Silano, Umberto Volta, Alessandro De Vincenzi, Mariarita Dessì, Massimo De Vincenzi, The Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Patients with celiac disease have an increased rate of enteropathy-associated T-cell lymphoma, but conflicting data are available about the protective role of a gluten-free diet with regard to the development of this malignancy. We followed 1,757 celiac patients for a total period of 31,801 person-years, collecting data about the frequency of gluten intake and the incidence of the enteropathy-associated T-cell lymphoma. Out of the nine celiac patients who developed an intestinal lymphoma [standard morbidity ratio of 6.42 (95% CI = 2.9–12.2; P < 0.001)], only two kept a strict gluten-free diet after the diagnosis of celiac diasese and developed the malignancy after the peridiagnosis period of 3 years, dropping therefore the standard morbidity ratio to 0.22 (95%CI = 0.02–0.88; P < 0.001). The risk of developing an intestinal lymphoma for the celiac patients that used to have dietary gluten was significant (X= 4.8 P = 0.01). These results show that a strict gluten-free diet is protective towards the development of enteropathy-associated T-cell lymphoma.
Literatur
1.
Zurück zum Zitat O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, Weir DG (1986) Humoral response to wheat protein in patients with coeliac disease and enteropathy-associated T-cell lymphoma. Br Med J 293:908–910CrossRef O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, Weir DG (1986) Humoral response to wheat protein in patients with coeliac disease and enteropathy-associated T-cell lymphoma. Br Med J 293:908–910CrossRef
2.
Zurück zum Zitat Howdle PD, Jalal PK, Holmes GK, Houlston RS (2003) Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96:345–353PubMedCrossRef Howdle PD, Jalal PK, Holmes GK, Houlston RS (2003) Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96:345–353PubMedCrossRef
3.
Zurück zum Zitat Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19:401–412PubMedCrossRef Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19:401–412PubMedCrossRef
4.
Zurück zum Zitat Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ (2004) Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol 241:78–84CrossRef Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ (2004) Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol 241:78–84CrossRef
5.
Zurück zum Zitat Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR (2002) Italian Working Group on Coeliac Disease and Non-Hodgkin’s-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287:1413–1419PubMedCrossRef Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR (2002) Italian Working Group on Coeliac Disease and Non-Hodgkin’s-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287:1413–1419PubMedCrossRef
6.
Zurück zum Zitat West J, Logan RF, Smith CJ, Hubbard RB, Card TR (2004) Malignancy and mortality in people with coeliac disease: population-based cohort study. BMJ 329:716–719PubMedCrossRef West J, Logan RF, Smith CJ, Hubbard RB, Card TR (2004) Malignancy and mortality in people with coeliac disease: population-based cohort study. BMJ 329:716–719PubMedCrossRef
7.
Zurück zum Zitat Holmes GK, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease-effect of a gluten-free diet. Gut 30:333–338PubMedCrossRef Holmes GK, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease-effect of a gluten-free diet. Gut 30:333–338PubMedCrossRef
8.
Zurück zum Zitat Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A (1994) Coeliac disease: associated disorders and survival. Gut 35:1215–1218PubMedCrossRef Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A (1994) Coeliac disease: associated disorders and survival. Gut 35:1215–1218PubMedCrossRef
9.
Zurück zum Zitat Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428–1435PubMedCrossRef Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428–1435PubMedCrossRef
10.
Zurück zum Zitat Silano M, Volta U, Mecchia AM, Dessi M, Di Benedetto R, De Vincenzi M, Collaborating centers of the Italian registry of the complications of coeliac disease (2007) Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 9:8CrossRef Silano M, Volta U, Mecchia AM, Dessi M, Di Benedetto R, De Vincenzi M, Collaborating centers of the Italian registry of the complications of coeliac disease (2007) Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 9:8CrossRef
11.
Zurück zum Zitat Swinson CM, Slavin G, Coles EC, Booth CC (1983) Coeliac disease and malignancy. Lancet 1:111–115PubMedCrossRef Swinson CM, Slavin G, Coles EC, Booth CC (1983) Coeliac disease and malignancy. Lancet 1:111–115PubMedCrossRef
12.
Zurück zum Zitat Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115:191–195PubMedCrossRef Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115:191–195PubMedCrossRef
13.
Zurück zum Zitat Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003) Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163:1566–1572PubMedCrossRef Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003) Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163:1566–1572PubMedCrossRef
14.
Zurück zum Zitat Catassi C, Bearzi I, Holmes GK (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128:S79–S86PubMedCrossRef Catassi C, Bearzi I, Holmes GK (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128:S79–S86PubMedCrossRef
15.
Zurück zum Zitat Martin-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castano L, Vitoria JC (2007) Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 40:117–121PubMedCrossRef Martin-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castano L, Vitoria JC (2007) Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 40:117–121PubMedCrossRef
16.
Zurück zum Zitat National Institutes of Health (2005) Consensus Development Conference Statement on Celiac Disease. Gastroenterology 128:S1–S9CrossRef National Institutes of Health (2005) Consensus Development Conference Statement on Celiac Disease. Gastroenterology 128:S1–S9CrossRef
18.
Zurück zum Zitat Card TR, West J, Holmes GK (2004) Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20:769–775PubMedCrossRef Card TR, West J, Holmes GK (2004) Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20:769–775PubMedCrossRef
19.
Zurück zum Zitat Freeman HJ (2004) Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 38:429–434PubMedCrossRef Freeman HJ (2004) Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 38:429–434PubMedCrossRef
20.
Zurück zum Zitat Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT (1976) Coeliac disease, gluten-free diet, and malignancy. Gut 17:612–619PubMedCrossRef Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT (1976) Coeliac disease, gluten-free diet, and malignancy. Gut 17:612–619PubMedCrossRef
21.
Zurück zum Zitat Goddard CJ, Gillett HR (2006) Complications of coeliac disease: are all patients at risk? Postgrad Med J 82:705–712PubMedCrossRef Goddard CJ, Gillett HR (2006) Complications of coeliac disease: are all patients at risk? Postgrad Med J 82:705–712PubMedCrossRef
Metadaten
Titel
Effect of a Gluten-free Diet on the Risk of Enteropathy-associated T-cell Lymphoma in Celiac Disease
verfasst von
Marco Silano
Umberto Volta
Alessandro De Vincenzi
Mariarita Dessì
Massimo De Vincenzi
The Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease
Publikationsdatum
01.04.2008
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2008
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9952-8

Weitere Artikel der Ausgabe 4/2008

Digestive Diseases and Sciences 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.